1. ALLA AKTIER
  2. NYHETER
  3. SPAGO NANOMEDICAL

Spago Nanomedical

Nyheter Spago Nanomedical Nyheter alla bolag
Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.

Spago Nanomedical publishes the annual report for 2024

MARKN.

Spago Nanomedical's annual report for 2024 is from today available at the company’s website, https://spagonanomedical.se/investor-relations/#financial-reports

For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, mats.hansen@spagonanomedical.se

Spago Nanomedical AB is a Swedish company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise treatment and diagnosis of cancer and other debilitating diseases. Spago Nanomedical´s share is listed on Nasdaq First North Growth Market (ticker: SPAGO). For further information, see www.spagonanomedical.se.

FNCA Sweden AB is the Certified Adviser of the company.

Attachments

Spago Nanomedical AB Annual Report 2024

Datum 2025-04-15, kl 11:15
Källa MFN
Bifogade filer
Spago Nanomedical AB Annual Report 2024